Cambium Bio
CompanySydney, Australia· Biotech
Australian regenerative medicine company developing a treatment for dry eye disease.
Minutes holds 1 development and 1 deal naming Cambium Bio, recorded from September 2026.
Intelligence
Deals in Minutes
| Company | Deal | Amount | Counterparties | Date ↓ | Status |
|---|---|---|---|---|---|
| Cambium BioBiotech | FundingPlacement | AUD 10.85M | Not recorded | 16 Sep | Closed |